• DNDi - Best Science for the Most Neglected 20 Years
  • Our work
    • Diseases
      • Sleeping sickness
      • Visceral leishmaniasis
      • Cutaneous leishmaniasis
      • Chagas disease
      • Filaria: river blindness
      • Mycetoma
      • Paediatric HIV
      • Cryptococcal meningitis
      • Hepatitis C
      • Dengue
      • COVID-19
      • Antimicrobial resistance
    • Research & development
      • R&D portfolio & list of projects
      • Drug discovery
      • Translational research
      • Clinical trials
      • Registration & access
      • Treatments delivered
    • Advocacy
      • Open and collaborative R&D
      • Transparency of R&D costs
      • Pro-access policies and IP
      • Children’s health
      • Gender equity
      • Climate change
      • AI and new technologies
  • Networks & partners
    • Partnerships
      • Our partners
      • Partnering with us
    • Global networks
      • Chagas Platform
      • Dengue Alliance
      • HAT Platform
      • HELP Helminth Elimination Platform
      • LEAP Platform
      • redeLEISH Network
    • DNDi worldwide
      • DNDi Switzerland
      • DNDi DRC
      • DNDi Eastern Africa
      • DNDi Japan
      • DNDi Latin America
      • DNDi North America
      • DNDi South Asia
      • DNDi South-East Asia
      • DNDi Southern Africa
  • News & resources
    • News & stories
      • News
      • Stories
      • Statements
      • Viewpoints
      • Social media
      • eNews Newsletter
    • Press
      • Press releases
      • In the media
    • Resources
      • Scientific articles
      • Our publications
      • Videos
    • Events
  • About us
    • About
      • Who we are
      • How we work
      • Our strategy
      • Our donors
      • Annual reports
    • Our people
      • Our leadership
      • Our governance
      • Contact us
    • Work with us
      • Working at DNDi
      • Job opportunities
      • Requests for proposal
  • Donate
DNDi - Best Science for the Most Neglected 20 Years
  • DNDi - Best Science for the Most Neglected 20 Years
  • Our work
    • Diseases
      • Sleeping sickness
      • Visceral leishmaniasis
      • Cutaneous leishmaniasis
      • Chagas disease
      • Filaria: river blindness
      • Mycetoma
      • Paediatric HIV
      • Cryptococcal meningitis
      • Hepatitis C
      • Dengue
      • COVID-19
      • Antimicrobial resistance
    • Research & development
      • R&D portfolio & list of projects
      • Drug discovery
      • Translational research
      • Clinical trials
      • Registration & access
      • Treatments delivered
    • Advocacy
      • Open and collaborative R&D
      • Transparency of R&D costs
      • Pro-access policies and IP
      • Children’s health
      • Gender equity
      • Climate change
      • AI and new technologies
  • Networks & partners
    • Partnerships
      • Our partners
      • Partnering with us
    • Global networks
      • Chagas Platform
      • Dengue Alliance
      • HAT Platform
      • HELP Helminth Elimination Platform
      • LEAP Platform
      • redeLEISH Network
    • DNDi worldwide
      • DNDi Switzerland
      • DNDi DRC
      • DNDi Eastern Africa
      • DNDi Japan
      • DNDi Latin America
      • DNDi North America
      • DNDi South Asia
      • DNDi South-East Asia
      • DNDi Southern Africa
  • News & resources
    • News & stories
      • News
      • Stories
      • Statements
      • Viewpoints
      • Social media
      • eNews Newsletter
    • Press
      • Press releases
      • In the media
    • Resources
      • Scientific articles
      • Our publications
      • Videos
    • Events
  • About us
    • About
      • Who we are
      • How we work
      • Our strategy
      • Our donors
      • Annual reports
    • Our people
      • Our leadership
      • Our governance
      • Contact us
    • Work with us
      • Working at DNDi
      • Job opportunities
      • Requests for proposal
  • Donate
Home > Events

ASTMH 2018

28 October - 1 November 2018

New Orleans, USA

Share on twitter
Share on facebook
Share on linkedin
Share on email
Share on print

67th Annual Meeting

The 67th American Society of Tropical Medicine and Hygiene (ASTMH) annual meeting is designed for researchers, professors, government and public health officials, military personnel, travel clinic physicians, practicing physicians in tropical medicine, students and all health care providers working in the fields of tropical medicine, hygiene and global health. 

You can find DNDi at Booth #318!

Download DNDi @ ASTMH 2018

Symposia

From R&D to access for sleeping sickness elimination: Innovative public-private partnerships for new tools

Co-organized by Sanofi and DNDi

Date: Monday, 29 October 2018
Time: 19:15-21:15
Venue: Sheraton – Waterbury (2nd floor)

Chairs: Victor Kande Betu Kumeso, Ministry of Health, DRC, Luc Kuykens, Senior Vice President Global Health Programs, Sanofi, France & Bernard Pécoul, Executive Director, DNDi

An alternative model for drug development: The story of fexinidazole
Nathalie Strub-Wourgaft, NTD Director, DNDi, Geneva

Working in partnership for sleeping sickness elimination: Using new technologies
Florent Mbo, HAT Platform Coordinator, DRC (presenting on behalf of Eric Mwamba Miaka, Director National HAT Programme, DRC)

Finding every last case: The role of diagnostics in HAT elimination
Veerle Lejon, Research Director, Institut de Recherche pour le Développement (IRD), France

Importance of the development of an oral treatment for sleeping sickness through public-private partnership
Luc Kuykens, Senior Vice President Global Health Programs, Sanofi, France

Striving towards HAT elimination in South Sudan: An operational perspective
Laurence Flevaud, Operational Center Barcelona-Athens, MSF
Monitoring HAT elimination: Plans for validation
Gerardo Priotto, Department of Control of Neglected Tropical Diseases, WHO, Switzerland

 

Overcoming challenges in screening and diagnosis of Chagas disease

Date: Tuesday 30 October 2018
Time: 13:45-15:30
Venue: Sheraton – Oak Alley (4th Floor) / Sheraton – Waterbury (2nd floor)

Co-chairs: Sergio Sosa Estani, Head of Chagas Clinical Programme, DNDi Latin America & Colin Forsyth, Chagas Epidemiologist, DNDi North America

Differing responses to CD immunoassays: T. cruzi genetic diversity vs. host immune response
Claudia Herrera, Tulane University, New Orleans, USA

Latest developments in biomarkers research
Eric Chatelain, Head of Drug Discovery Programme, DNDi, Switzerland

Community-Based screening of Chagas disease in the USA: Boston’s Strong Hearts Program
Julia Koehler, Boston Children’s Hospital, Boston, USA

Implementation of a simplified diagnostic algorithm in an endemic area of Colombia
Colin Forsyth, Chagas Epidemiologist, DNDi North America

Oral presentations

Date: Sunday, 28 October 2018 & Monday, 29 October 2018
Time: 10:00-15:00 / 8:30-8:45
Venue: Sheraton – Waterbury (2nd floor)

The burden of skin disease and eye disease due to onchocerciasis in Africa for 1990, 2015 and 2025
Vinkeles Melchers NVS, Stolk WA, Remme JHF, Murdoch ME, Pedrique B, Bakker R, de Vlas SJ, Coffeng LE 

Date: Monday, 29 October 2018
Time: 15:00-15:15
Venue: Sheraton – Rhythms (2nd floor)

Novel 3-Dimensional Optical Scanning in the assessment of patients with mycetoma
Siddig E, Liberton N, van Eijnatten M, te Slaa S, Faroog A, Fahal AH, Wolff J, Zijlstra EE

Date: Wednesday, 31 October 2018
Time: 8:15-8:30
Venue: Sheraton – Rodrigue Gallery (1st floor)

Pharmacokinetic-pharmacodynamic assessment of the safety of fexinidazole for the treatment of human African trypanosomiasis
Watson J, Strub-Wourgraft N, Tarral A, Tarning J, White NJ

Date: Wednesday, 31 October 2018
Time: 9:30-9:45
Venue: Sheraton – Rodrigue Gallery (1st floor)

Modeling and simulations of fexinidazole treatment regiment for human African trypanosomia brucei gambiense trypanosomiasis (g-HAT) and their successful clinical application in adult and child patients
Gualano V, Felices M, Tarral A

Date: Thursday, 1 November 2018
Time: 10:30-10:45
Venue: Sheraton – Rodrigue Gallery (1st floor)

Oxfendazole treatment has a macrofilaricidal efficacy against the filarial nematode Litomosoides sigmodontisin vivo and inhibits Onchocerca gutturosa adult worm motility in vitro
Hübner MP, Martin C, Specht S, Koschel M, Dubben B, Frohberger SJ, Ehrens A, Fendler M, Struever D, Vallarino-Lhermitte N, Gokooi S, Townson S, Hoerauf A, Scandale I

Poster presentations

Date: Monday, 29 October 2018
Time: 12:00-13:45
Venue: Marriott – Grand Ballroom (3rd floor)

The Chagas disease study landscape: preliminary results of a systematic review of clinical and observational studies to assess the feasibility of establishing an individual participant-level data (IPD) platform
Maguire BJ, Guérin PJ, Chatelain E, Sosa Estani S, Barreira F

A single-center, first-in-human, randomized, double-blind, placebo-controlled, parallel-group study to investigate the safety, tolerability and pharmacokinetics of escalating single doses of emodepside (BAY44-4400) in healthy male subjects
Gillon JYA, van den Berg F, Dequatre Cheeseman K, Hopchet N, Delhomme S, Peña Rossi C, Monnot F, Strub-Wourgaft N, Rodriguez ML, Don R.

Capacity Building Platform for clinical and operational research on human African trypanosomiasis
Mbo F, Valverde O

Date: Tuesday, 30 October 2018
Time: 12:00-13:45
Venue: Marriott – Grand Ballroom (3rd floor)

Prioritizing pathogens to support diagnostic product development for febrile illness management: a novel yet pragmatic approach
Roddy P, Osborn J, Roberts T, Guillen E, Bernal O, Ongarello S, Sprecher A, Page AL, Ribeiro I, Piriou E, Tamrat A, de la Tour R, Rao B, Flevaud L, Jensen T, McIver L, Kelly C, Dittrich S

Evaluation of point-of-care tests for visceral leishmaniasis diagnosis in Kenya
Mbuchi M, Ndung’u JM, Wasunna M, Osuna F, Magiri CG, Muia A, Kioko P, Bakari M, Mwathe F, Ronoh R, Abner E, Chirchir M, Njenga S, Kirigi G, Kimutai R, Cruz I

 

Date: Wednesday, 31 October 2018
Time: 12:00-13:45
Venue: Marriott – Grand Ballroom (3rd floor)

Determination of fexinidazole effect on QTc in healthy volunteers and human African Trypanosomia brucei gambiense trypanosomiasis(g-HAT) patients using concentration-response modelling
Tarral A, Felices M, Voirot P

Sequential versus classical designs for early phase drug trials against visceral leishmaniasis
Alexander ND, Alves F, Balasegaram M, Blesson S, Burza S, Edwards T, Omollo R, Wasunna M

More information:

  • Event website
  • Programme

Other events

Loading...
22 May 2023, 5:45 PM

Geneva, Switzerland

Strengthening UHC through innovative & inclusive tools

8-12 May 2023

Lisbon, Portugal and online

ESPID 2023

13 April 2023, 2 PM London

London, United Kingdom

Ending the neglect of Chagas disease in the UK

11-12 April 2023

Barcelona, Spain and online

XVIII Jornadas sobre la enfermedad de Chagas

See all

Stay connected

Get our latest news, personal stories, research articles, and job opportunities. 

DNDi - Best Science for the Most Neglected 20 Years
Facebook-f
Twitter
Instagram
Linkedin-in
Youtube
International non-profit developing safe, effective, and affordable treatments for the most neglected patients.

Learn more

  • Diseases
  • Neglected tropical diseases
  • R&D portfolio
  • Policy advocacy

Get in touch

  • Our offices
  • Contact us
  • Integrity Line

Support us

  • Donate
  • Subscribe to eNews

Work with us

  • Join research networks
  • Jobs
  • RFPs
  • Terms of Use   
  •   Acceptable Use Policy   
  •   Privacy Policy   
  •   Cookie Policy   
  •   Our policies   

  • Except for images, films and trademarks which are subject to DNDi’s Terms of Use, content on this site is licensed under a Creative Commons Attribution-NonCommercial-Share Alike 3.0 Switzerland License   
We use cookies to track our audience and improve our content. By clicking 'Accept All', you are agreeing to our use of cookies. Click on 'Customize' to accept only some cookies.
Customize
REJECT ACCEPT ALL
Manage consent

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.
CookieDurationDescription
cookielawinfo-checkbox-advertisement1 yearSet by the GDPR Cookie Consent plugin, this cookie is used to record the user consent for the cookies in the "Advertisement" category .
cookielawinfo-checkbox-analytics11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional11 monthsThe cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
CookieLawInfoConsent1 yearRecords the default button state of the corresponding category & the status of CCPA. It works only in coordination with the primary cookie.
PHPSESSIDsessionThis cookie is native to PHP applications. The cookie is used to store and identify a users' unique session ID for the purpose of managing user session on the website. The cookie is a session cookies and is deleted when all the browser windows are closed.
viewed_cookie_policy11 monthsThe cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.
Functional
Functional cookies help to perform certain functionalities like sharing the content of the website on social media platforms, collect feedbacks, and other third-party features.
CookieDurationDescription
elementorneverThis cookie is used by the website's WordPress theme. It allows the website owner to implement or change the website's content in real-time.
Analytics
Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics the number of visitors, bounce rate, traffic source, etc.
CookieDurationDescription
_ga2 yearsThe _ga cookie, installed by Google Analytics, calculates visitor, session and campaign data and also keeps track of site usage for the site's analytics report. The cookie stores information anonymously and assigns a randomly generated number to recognize unique visitors.
_ga_16Q5RH3XRG2 yearsThis cookie is installed by Google Analytics.
_gat_UA-10302561-11 minuteA variation of the _gat cookie set by Google Analytics and Google Tag Manager to allow website owners to track visitor behaviour and measure site performance. The pattern element in the name contains the unique identity number of the account or website it relates to.
_gid1 dayInstalled by Google Analytics, _gid cookie stores information on how visitors use a website, while also creating an analytics report of the website's performance. Some of the data that are collected include the number of visitors, their source, and the pages they visit anonymously.
_hjAbsoluteSessionInProgress30 minutesHotjar sets this cookie to detect the first pageview session of a user. This is a True/False flag set by the cookie.
_hjFirstSeen30 minutesHotjar sets this cookie to identify a new user’s first session. It stores a true/false value, indicating whether it was the first time Hotjar saw this user.
_hjIncludedInPageviewSample2 minutesHotjar sets this cookie to know whether a user is included in the data sampling defined by the site's pageview limit.
_hjIncludedInSessionSample2 minutesHotjar sets this cookie to know whether a user is included in the data sampling defined by the site's daily session limit.
_hjSession_112884430 minutesHotjar sets this cookie.
_hjSessionUser_11288441 yearHotjar sets this cookie.
CONSENT2 yearsYouTube sets this cookie via embedded youtube-videos and registers anonymous statistical data.
Targeting
Advertisement cookies are used to provide visitors with relevant ads and marketing campaigns. These cookies track visitors across websites and collect information to provide customized ads.
SAVE & ACCEPT
Powered by CookieYes Logo